SEC Form 8-K Summary
Business context and reporting period
Registrant: Kensington Capital Acquisition Corp. IV, in connection with its proposed business combination with Amprius Technologies, Inc.
Report date: September 9, 2022; earliest reported event: September 9, 2022. The filing reports additional financing commitments related to the proposed Business Combination, which was previously announced on May 11, 2022.
Key transaction and financial terms
| Item | Terms |
|---|---|
| Additional PIPE | 215,000 PIPE Units sold to certain entities that previously invested in an Amprius affiliate |
| PIPE price | $10.00 per PIPE Unit |
| Total PIPE | 1,552,500 PIPE Units, including the previously announced 1,337,500 units |
| Gross PIPE proceeds | $15.525 million |
| Unit composition | One share of New Amprius Common Stock and one PIPE Warrant |
| PIPE Warrant exercise price | $12.50 per share |
| Warrant redemption threshold | New Amprius Common Stock average sales price must exceed $20.00 per share, subject to the warrant terms |
The PIPE closing is contingent on customary conditions, including substantially concurrent consummation of the Business Combination. Proceeds are intended to provide capital to the combined company, offset potential shareholder redemptions, and potentially satisfy the Minimum Cash Condition.
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or operating-performance metrics for Amprius or Kensington.
Material changes versus the prior comparable period
This is a transaction-related 8-K rather than a periodic financial report. The material change is the addition of 215,000 PIPE Units and $2.15 million of associated gross proceeds, increasing the total PIPE to 1,552,500 units and $15.525 million of gross proceeds. No comparable-period financial results are presented.
Guidance, outlook, risks, and unusual items
- Kensington agreed to file, within 30 calendar days after closing, a resale registration statement covering the PIPE shares and shares issuable upon exercise of the PIPE Warrants, and to use commercially reasonable efforts to have it declared effective promptly.
- The PIPE Warrants will be substantially similar to Kensington’s public warrants but will have a higher exercise price, a higher redemption threshold, and will not be exchange-listed.
- The securities are expected to be issued without registration under the Securities Act in reliance on Section 4(a)(2) and/or Regulation D.
- Completion of the Business Combination and PIPE remains subject to conditions including regulatory approvals, shareholder approvals, and the level of redemption requests.
- Identified risks include failure or delay in closing, inability to realize anticipated transaction benefits, production and facility delays, supply shortages, competition, government incentive changes, financing availability, and execution of Amprius’s business milestones.
- The filing provides no formal operating or financial guidance.
Most important facts to verify
- Whether the Business Combination receives the required shareholder and regulatory approvals and closes as expected.
- Whether all 1,552,500 PIPE Units are funded and issued, and whether the $15.525 million gross proceeds are received.
- The final amount of Kensington shareholder redemptions and compliance with the Minimum Cash Condition.
- The post-closing capitalization, including dilution from PIPE shares, public warrants, and PIPE Warrants.
- Whether the resale registration statement is filed within the required 30-day period and becomes effective.
- The financial and operating information in the related Form S-4, proxy statement/prospectus, and subsequent periodic filings.